Delivery Order SPE2DR25D9114-SPE2DR26FMFG4

Award Date 6/25/26

Potential Completion Date 7/17/26

Potential Value $21K

Federal Agency

Defense Logistics Agency

Awardee

DMS Pharmaceutical Group Inc. PX72BSBQTKJ3

Ultimate Awardee

Not listed

NAICS Category

424210 - Drugs and Druggists' Sundries Merchant Wholesalers

PSC Category

6505 - Drugs And Biologicals

Federal Contract Vehicle

Not listed

Set-Aside Type

No Set-Aside Used

Extent Competed

Full and Open Competition

Major Defense Program

Not listed

Pricing Type

Firm Fixed Price

Place of Performance

Park Ridge, IL 60068, USA

Solicitation Procedures

Negotiated Proposal / Quote

Number Of Offers Received

Not listed

Legislative Mandate

Not listed

National Interest Action

Not listed

Research Type

Not listed

Primary Consortia Member

Not listed

The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on June 25, 2026, for Xolair 300 mg/2 ml autoinjector with a ceiling value of $20,969.28.

The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract authorizing DMS Pharmaceutical as the sole regional prime vendor for pharmaceutical products and medical consumables supporting Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical is a woman-owned small business headquartered in Park Ridge, Illinois.

Place of performance is Park Ridge, IL. The order has an ultimate completion date of July 17, 2026, and is priced on a firm fixed-price basis.

Generated 9/26/26, 9:51 AM